Introduction
Despite the availability of effective antiretroviral therapy, over one quarter people (22 000) in the UK with human immunodeficiency virus (HIV) remain undiagnosed and untreated, 1 resulting in late presentation 2 with increased morbidity and mortality 3 and greater potential for onward transmission of infection. 4 Many patients who are diagnosed with advanced disease have accessed healthcare in the months or years before eventual diagnosis, suggesting missed opportunities for earlier testing, initiation of treatment and prevention of transmission. 3 In 2007, the UK Chief Medical Officer wrote to all doctors in the UK asking for help to reduce the public health burden of undiagnosed HIV. In 2008, the British HIV Association, British Association for Sexual Health and HIV and the British Infection Society jointly released national guidelines to encourage HIV testing in at-risk individuals.
guidelines was the identification, as a risk group, of patients with 'indicator diseases'-diseases epidemiologically linked with HIV infection but not acquired immunodeficiency syndrome (AIDS)-defining-and the revised pre-test discussion simplifying and normalizing the consent process.
Acute medical admissions units treat many patients with indicator diseases, and those that serve high-prevalence populations admit patients in other high-risk groups [e.g. migrants from endemic countries, injecting drug users and men who have sex with men (MSM)]. In contrast to community outpatient settings such as sexual health and antenatal services, where routine HIV testing has been introduced effectively (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/ 1227515298354) there are specific operational challenges associated with implementing enhanced HIV testing protocols, either routine or targeted, in acute hospital settings. Short length of stay, rapid staff turnover and varying skill mix all make it difficult to standardize testing and ensure robust mechanisms for provision of results in these settings. Furthermore, despite local and national surveillance data (http://www.hpa.org.uk/web/HPAwebFile/ HPAweb_C/1227515298354) for the established risk groups, there are no seroprevalence data for indicator diseases per se.
We audited HIV testing rates and seroprevalence among adults admitted with indicator diseases to an inner London teaching hospital acute admissions unit (AAU) and examined the impact of a protocol on testing rates and concordance with recommended consent and follow-up procedures. The AAU of University College London Hospitals, National Health Service Foundation Trust (UCLH) admits approximately 9000 adults per year. The majority are admitted from the accident and emergency unit, with some admitted from outpatient clinics. Most acute medical admissions are treated in the AAU, under Acute Medical teams, with specialist input as required, for the first 48 h of their stay and thereafter discharged home or triaged to hospital wards and specialist teams. Consultants from medical specialities rotate cover of AAU every week. A guideline on HIV testing was introduced on the 1 June 2008 in an attempt to improve HIV testing rates (Figure 1 ). This was supported by a pathway for providing results to discharged patients, in person or by letter, depending on the risk. The guideline was posted with other Acute Medicine protocols in the doctors' office and on the relevant shared drive. Consultants were informed at a clinical governance meeting and by email, and trainees were given a brief education session.
Methods
Between 15 April and 18 July 2008 (6 weeks preand post-HIV testing protocol introduction), an audit of two patient groups was performed: indicator diseases commonly presenting to acute medical settings (Table 1 ). (ii) All patients admitted to AAU who were tested for HIV infection (using an electronic database of pathology requests), not necessarily those with indicator diseases.
The principal outcome measure was an HIV test, defined as an HIV test recorded on the electronic database within 1 month of admission. HIV testing rates before and after introduction of the guidelines were compared. Preliminary data from our hospital suggested that approximately 30 patients with indicator diseases are admitted to AAU over a 6-week period (unpublished data, M. Brown). This study period would have 80% power to detect a doubling of testing rates (6 weeks post-vs. 6 weeks pre-intervention), an increase seen in successful interventions for HIV testing in US emergency settings. 6 Electronic data retrieval systems were used to obtain information on diagnoses, ethnicity, length of stay, previous HIV tests and testing status on this admission. Subsequently, the clinical notes for these admissions were interrogated for documented information about HIV risk factors, involvement of infection specialists and consent processes.
For descriptive analyses, standard bivariate statistical tests, including 2 -test and Fisher's exact test, were calculated. Data were analysed in Statistical Package for the Social Sciences (SPSS) v.12.
Results
A total of 65 patients, aged 19-64 years (mean age 38.6 years) and 59% males, with indicator diseases were admitted between 15 April and 18 July 2008. One-half (50%) of patients were discharged within 48 h and 27 (42%) were admitted prior to implementation of the protocol (1 June 2008). Nine patients were known to have HIV infection before admission; five (56%) were admitted with bacterial pneumonia, constituting a prevalence of diagnosed HIV infection among patients with pneumonia of 21%, and among patients with any indicator disease of 15%. Of the remaining 56 patients, 24 (43%) were admitted with pneumonia and 18 (32%) with unexplained fever. An HIV test was performed on 16 patients (29%), of whom one (6%) with pneumonia was found to be HIV infected. HIV testing was more common among patients who stayed in hospital for > 2 days (48% vs. 15%, P = 0.008). There was no difference in testing rates before and after the introduction of the protocol (29% vs. 28%, P = 0.932).
Clinical case notes were available for 50 patients. HIV testing was offered to 12 patients, of whom one refused and one was not subsequently tested (the reason was not documented). Testing was significantly associated with longer length of stay, involvement of infectious disease (ID) specialists and diagnosis of pneumonia or unexplained fever, weight loss or lymphadenopathy (Table 2) .
Thirty-six patients admitted to AAU over the same 12-week period (not only those with indicator diseases) were tested for HIV, of whom one was positive. The clinical case notes were available for 26 of these. Nearly one-fourth of patients tested were discharged within a day and over half were discharged within 48 h. After consultation by an ID specialist, 69% were tested. Consent was obtained by junior staff in >50% patients. Verbal consent to testing was documented in 58% cases; there was documentation of provision of negative results for two patients, although follow-up under ID specialists was arranged for 10 patients.
Discussion
In an inner London teaching hospital AAU, 15% patients (aged 19-64 years) admitted with indicator diseases were known to be, or newly diagnosed as, infected with HIV. Nine of ten HIV-infected patients were known to be positive before admission; however, only 29% patients not known to be infected before admission were tested, suggesting that the true prevalence in this setting may be higher. Most patients agreed to a test when offered. Introduction of a guideline with a limited training and awareness programme had no impact on testing rates in the short term.
This study focused on the immediate impact of a new guideline aimed at changing behaviour of the existing medical team. A larger study would have had more power to detect as statistically significant a small impact of the intervention on testing rates. However, there was no evidence of even a small impact on testing rates immediately after the guideline was introduced and publicized in the AAU. Given the high turnover of junior doctors on the ward (who rotate every 4-6 months), we would not have expected a longer study period to have detected a significant increase in testing, which if anything might have fallen off over time.
Testing was more common among patients admitted to hospital for longer. Only two indicator disease categories reliably triggered HIV testing: pneumonia and fever/weight loss/lymphadenopathy of unexplained origin. Although these findings are reassuring to an extent, almost one-fourth of those patients not offered a test had risk factors for HIV and nearly half presented with pneumonia or fever, weight loss or lymphadenopathy. The group of patients not tested for HIV, despite being of greater average age, was less likely to smoke or to have pneumonia.
A letter from the Chief Medical Officer in September 2007, recruiting the help of non-HIV specialists in combating HIV infection, did not translate into higher HIV testing rates in primary or secondary care. 7 Low HIV testing in acute healthcare settings may result from a number of factors, including physician reluctance to broach the subject of HIV testing, low patient appreciation of personal risk and ill health and patient refusal due to the stigmatizing reputation of HIV testing. 8 In the USA, 'opt-out' testing for HIV in all medical settings, in conjunction with rapid 'near-patient' testing technology, has been cost-effective in regions where seroprevalence exceeds 1 in 1000. 9 Testing rates increased and negative connotations associated with testing were reduced. Of note, more than half of patients diagnosed with HIV did not fall into obvious risk categories (http://www.cdc.gov/hiv/topics/testing/ resources/slidesets/pdf/USCA_Branson.pdf). In the UK, opt-out testing currently exists only in antenatal care and in an increasing number of sexual health clinics. The new UK guidelines advocate routine testing of all general medical admissions, but the feasibility, acceptability and cost-effectiveness of such an approach have not been studied.
Current National Health Service systems with quality targets focusing on early hospital discharge, high patient throughput and distant location of pathology from clinical areas create challenges for delivery of HIV testing. Our data demonstrate that, although 46% of tested patients were discharged within 48 h of admission and a protocol for provision of results to patients post-discharge was available, testing was more likely among patients admitted for longer. While there are potential confounding factors here, introduction of point-of-care testing (POCT) would likely improve testing uptake in this setting. 10 We recommend prospective interventional studies to further examine the benefits of POCT and opt-out strategies for HIV testing.
The new 2008 HIV guidelines 5 recommend that any trained health professional can obtain consent and that a lengthy consent process is not indicated. In particular, healthcare professionals are encouraged to normalize HIV testing, partly by moving away from obtaining a detailed sexual history unless the consultation requires it. Our results indicate, however, that the majority tests were recommended only after involvement of infection specialists. It is possible that the patients referred to ID specialists were those most likely to be at risk of HIV infection, hence the higher testing rate in this group. Lack of testing among young patients with indicator diseases was demonstrated and more effort needs to be made to transfer specialist knowledge and skills to all clinicians. Our hospital provides inpatient beds for one of the largest HIV outpatient services in the UK, which may partly explain the high prevalence of diagnosed HIV infection in this study. However, there are several other large hospitals in central London with similar HIV services, and the majority of HIV-infected patients admitted through AAU live locally. Recent Survey of Prevalent HIV Infections Diagnosed data suggest a high HIV prevalence in the local population comparable with most inner city boroughs (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_ C/1228207184991).
The 2008 UK guidelines state that the requesting healthcare professional is responsible for ensuring that the patient receives the result of his/her test, and recommend POCT in 'clinical settings where a rapid turnaround of testing results is desirable'. 5 We found that although documentation of the consent process was relatively good (58%), documentation of provision of HIV test results to patients occurred only twice (although outpatient ID service follow-up was arranged in 10 cases). POCT may therefore be appropriate for improving communication of test results to patients and subsequent follow-up as necessary.
Conclusions
Diagnosed HIV infection is common among young patients with indicator diseases admitted to an inner London AAU, whereas knowledge of, and compliance with, new UK guidelines on identifying undiagnosed HIV infection is low. More intensive training of medical students and qualified doctors should increase uptake, however, the constraints of acute hospital settings may limit the effectiveness of these guidelines. We propose that prospective studies of implementation of routine testing with near-patient technologies are needed to prevent missed opportunities to diagnose HIV and facilitate entry into care.
